<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01886625</url>
  </required_header>
  <id_info>
    <org_study_id>NL41466.042.12</org_study_id>
    <nct_id>NCT01886625</nct_id>
  </id_info>
  <brief_title>Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)</brief_title>
  <official_title>Single-port Thoracoscopic Sympathicotomy for Treatment of Complex Regional Pain Syndrome Type I, a Feasibility Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Groningen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background of the study: CRPS type-1 is a pain syndrome that usually develops after an&#xD;
      initiating noxious event (e.g. fracture) in an extremity. Although treatment options life&#xD;
      dimethyl-sulphoxide (DMSO), N-acetylcysteine (NAC) and intensive physical therapy exist, the&#xD;
      treatment effect is often unsatisfactory, even leading to amputation of the extremity.&#xD;
      Surgical treatment of chronic pain disorders by dividing the sympathetic chain is an&#xD;
      established treatment. Its more invasive nature has prevented widespread application. After&#xD;
      introduction of minimal invasive techniques in recent years, the UMCG has now devised a truly&#xD;
      minimal invasive, yet safe and effective thoracoscopic technique, that requires only a single&#xD;
      1 cm long incision in the anterior axillary line. This technique is developed as treatment&#xD;
      for primary focal axillary and palmar hyperhidrosis, and is performed in over 50 patients&#xD;
      producing very satisfying results. This fact has led to the hypothesis that this same&#xD;
      surgical technique can offer this group of chronic pain patients a safe, effective treatment&#xD;
      modality.&#xD;
&#xD;
      Objective of the study: The effect of the intervention on pain an regain of function in de&#xD;
      affected extremity. This will be quantified in multiple questionnaires at baseline and three&#xD;
      follow-up points, and by clinical evaluation of the hand function at baseline and two&#xD;
      follow-up points.&#xD;
&#xD;
      Study design: Single center prospective feasibility study&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No local inclusions&#xD;
  </why_stopped>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in perceived pain measured in Visual Analogue Scale</measure>
    <time_frame>Baseline, 1, 3 and 6 months postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in function in extremity</measure>
    <time_frame>Baseline, 1 and 6 months after intervention</time_frame>
    <description>Strength in fingers, maximal flexion/extension in all digits, volumetric measurement, timing simple daily tasks.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Complex Regional Pain Syndrome Type I of the Upper Limb</condition>
  <arm_group>
    <arm_group_label>Sympathicotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>unilateral single-port VATS sympathicotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>unilateral single-port VATS sympathicotomy</intervention_name>
    <arm_group_label>Sympathicotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 18 - 65 years.&#xD;
&#xD;
          -  ASA 1 en 2.&#xD;
&#xD;
          -  CRPS-1 defined according to IASP-Bruehl criteria at the wrist or lower arm level.&#xD;
&#xD;
               1. Continuing pain which is disproportionate to any inciting event&#xD;
&#xD;
               2. Must report at least one symptom in each of the four following categories&#xD;
&#xD;
                    -  Sensory: reports of hyperesthesia&#xD;
&#xD;
                    -  Vasomotor: reports of temperature asymmetry, skin color change or asymmetry.&#xD;
&#xD;
                    -  Sudomotor/edema: reports of edema, sweating changes, sweating asymmetry&#xD;
&#xD;
                    -  Motor/trophic: reports of decreased range of motion, motor dysfunction&#xD;
                       (weakness, tremor, dystonia), trophic changes (hair, nail, skin)&#xD;
&#xD;
               3. Must display at least one sign in two or more of the following categories:&#xD;
&#xD;
                    -  Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light&#xD;
                       touch)&#xD;
&#xD;
                    -  Vasomotor: evidence of temperature asymmetry, color changes, asymmetry&#xD;
&#xD;
                    -  Sudomotor/edema: evidence of edema, sweating changes, sweating asymmetry&#xD;
&#xD;
                    -  Motor/trophic: evidence of decreased range of motion, motor dysfunction&#xD;
                       (weakness, tremor, dystonia), trophic changes (hair, nail, skin)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Known COPD &gt; Gold class 1.&#xD;
&#xD;
          -  History of smoking &gt; 20 pack years, due to higher risk of complications following&#xD;
             unilateral lung- deflation and re-insufflation.&#xD;
&#xD;
          -  Documented substance addiction.&#xD;
&#xD;
          -  Previous intra-thoracic pleural drainage on affected side.&#xD;
&#xD;
          -  Previous thoracic surgery on affected side (including sternotomy). - Gross pulmonary&#xD;
             or pleural abnormalities on chest X-ray.&#xD;
&#xD;
          -  Pregnancy, determined by preoperative pregnancy test.&#xD;
&#xD;
          -  Unsuitable anatomy (e.g. due to severe physical malformations).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo A Mariani, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michiel Kuijpers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Centre Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>March 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2013</study_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Groningen</investigator_affiliation>
    <investigator_full_name>Michiel Kuijpers</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

